Daniele Lorenzini

Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

Caterina Bartolacci, Cristina Andreani, Gonçalo Vale et al. · Nature Communications · 2022 · 170 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

A. Raimondi, Sara Lonardi, Sabina Murgioni et al. · Annals of Oncology · 2024 · 72 citations · Full text

Medicine, Oncology, Pathology +17

Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

Benny Johnson, Cara Haymaker, Edwin R. Parra et al. · Journal for ImmunoTherapy of Cancer · 2022 · 52 citations · Full text

Medicine, Oncology, Pharmacology +17

Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up

Marco Invernizzi, Chiara Corti, Gianluca Lopez et al. · BMC Cancer · 2018 · 51 citations · Full text

Medicine, Oncology, Breast Oncology +16

Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases

Preeti Kanikarla Marie, Cara Haymaker, Edwin R. Parra et al. · Clinical Cancer Research · 2021 · 49 citations · Full text

Medicine, Oncology, Surgery +17